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Brain trauma triggers a cascade of deleterious events leading to enhanced incidence
of drug resistant epilepsies, depression, and cognitive dysfunctions. The underlying
mechanisms leading to these alterations are poorly understood and treatment that
attenuates those sequels are not available. Using controlled-cortical impact as an
experimental model of brain trauma in adult mice, we found a strong suppressive effect
of the sodium-potassium-chloride importer (NKCC1) specific antagonist bumetanide
on the appearance of depressive-like behavior. We demonstrate that this alteration in
behavior is associated with an impairment of post-traumatic secondary neurogenesis
within the dentate gyrus of the hippocampus. The mechanism mediating the effect of
bumetanide involves early transient changes in the expression of chloride regulatory
proteins and qualitative changes in GABA(A) mediated transmission from hyperpolarizing
to depolarizing after brain trauma. This work opens new perspectives in the early
treatment of human post-traumatic induced depression. Our results strongly suggest
that bumetanide might constitute an efficient prophylactic treatment to reduce
neurological and psychiatric consequences of brain trauma.
Keywords: psychiatric disease, depression, potassium chloride cotransporter 2 (KCC2), bumetanide,
neurogenesis, interneuron cell death
INTRODUCTION
Brain trauma is the main cause of disability all over the world with a very high prevalence
in developed countries (Meyer et al., 2008; Bondi et al., 2015). According to the World
Health Organization and the Centers for Disease Control and Prevention (Meyer et al.,
2008), brain trauma classification is based on multiple factors such as altered neurological
functions, brain area of interest and genetic variations. Altogether, these factors lead to highly
individualized injuries. Sequels of trauma include low prevalence post-traumatic epilepsies
(PTEs), with a severity and occurrence dependent on trauma severity (Kelly et al., 2015;
Bragin et al., 2016), and cognitive dysfunctions and depression-like phenotypes are also
commonly associated (Peeters et al., 2015; Perry et al., 2015; Stein et al., 2015). Following
brain trauma, neuronal cell death occurs and more particularly within the neurons of
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the dentate gyrus of the hippocampus (Ren et al., 2015; Samuels
et al., 2015), leading to hippocampal volume reduction (Samuels
et al., 2015; Anacker and Hen, 2017). These observations could
be related to changes in post-traumatic neurogenesis in the
hippocampus. This has been proposed to be a useful marker
of therapeutic treatment efficacy (Brandon and McKay, 2015;
Alvarez et al., 2016).
In a wide range of neurological and psychiatric disorders,
GABAergic signaling is affected through chloride homeostasis
impairment triggered by a down regulation of the main
neuronal-specific chloride and potassium extruder, KCC2, and
up regulation of the chloride importer NKCC1, respectively
(Medina et al., 2014). Similar changes in GABAergic transmission
have been reported in a different model of brain trauma
(Ben-Ari, 2017). This leads to depolarization and also an
excitatory action of GABA that could perturb the generation
of behaviorally relevant oscillations and integrative properties
of brain networks (Rivera et al., 1999; Luscher et al., 2011;
Kahle et al., 2013; Medina et al., 2014; Ben-Ari, 2017). These
shifts have been observed notably in developmental disorders
including autism spectrum disorders (ASDs) (Tyzio et al., 2014),
stroke (Jaenisch et al., 2010; Xu et al., 2016) and epilepsy
(Pallud et al., 2014; Tyzio et al., 2014; Kelley et al., 2016).
The interaction between major depressive disorders (MDDs)
and GABAergic neurotransmission has been suggested in a
genetic mice model of GABA(B)-R knock-out (Mombereau et al.,
2005) and in studies showing an antidepressant effect of potent
and selective blockage of GABA(A) transmission (Rudolph and
Knoflach, 2011) at both the hippocampus (Boldrini et al.,
2013) and mesolimbic system (Kandratavicius et al., 2014).
In addition, several observations link chloride homeostasis to
secondary neurogenesis through GABA(A) neurotransmission
(Luscher et al., 2011; Ostroumov et al., 2016). The generation
of new neurons within the DG requires different steps: first,
the transition from quiescent to proliferative progenitors, then
their differentiation to immature neurons in a GABAergic-
dependent manner (Chell and Frisén, 2012; Moss and Toni,
2013). In that context, it’s well-accepted that brain trauma alters
neurogenesis (Perry et al., 2015; Stein et al., 2015). In the past
decade, the relationship between GABA neurotransmission and
neurogenesis has been well-established. Ge and collaborators
have shown that GABA receptors are expressed in the progenitor
cells and that GABA itself, either ambient or synaptically-
released GABA, could act at different steps during neurogenesis
from proliferation to cell differentiation and finally synaptic
integration (Ge et al., 2006; Anacker and Hen, 2017). In
addition, the GABAergic polarity acts on the cell integration
(Ge et al., 2006) but also in cell proliferation (Sun et al.,
2012), thus establishing a causal link between cell cycling and
cell cycle exit on depolarizing GABA condition (Scharfman
and Bernstein, 2015; Hu J.J. et al., 2017). Apart from the
monoamine hypothesis, a new theory based on the GABA release
itself has been proposed to contribute to depression. GABA
release has been demonstrated to be impaired in psychiatric
disorders and particularly in depression (Luscher et al., 2011;
Gabbay et al., 2012). More particularly, the GABAergic receptors
have been shown to be decreased in expression and function
in the dentate gyrus of depressed patients (Luscher et al.,
2011; Lüscher and Fuchs, 2015) and brain tissues collected
from suicide patients with a history of depression and anxiety
(Merali et al., 2004). One of the first phenomenon linking
depression and the hippocampus is the change in hippocampal
volume observed both in rodent and in human (Savitz et al.,
2010; Schuhmacher et al., 2013; Roddy et al., 2018). This is
a common trait observed when the hypothalamic–pituitary–
adrenal (HPA) axis is impaired. Other brain regions such as
cingulate cortex, prefrontal cortex or even amygdala are also
associated with depression (Drevets et al., 2008). In addition to
volume changes other functions are changed in the hippocampus
of animal displaying DLB, e.g., modified volume (Roddy et al.,
2018), impaired GABAergic function (Merali et al., 2004),
increase in excitability and monoamine dysfunction (Samuels
et al., 2015) as well as impaired secondary neurogenesis and
cognitive deficit (Ferguson et al., 2016; Anacker and Hen,
2017). Taken together, this makes the hippocampal formation
a important and valuable structure to study depression in TBI
models.
Parvalbumin-containing interneurons are the principal source
of GABA release within the dentate gyrus and thus potential
candidates to explain controlled-cortical impact (CCI)-induced
dysregulations through their role in the synchronicity of
hippocampal networks (Curia et al., 2008; Drexel et al., 2011;
Shiri et al., 2014). Moreover, it is accepted that the activity of
this class of interneurons could act on secondary neurogenesis
by providing a source of ambient GABA (Song et al., 2012;
Butler et al., 2016; Hu D. et al., 2017; Pérez-Domínguez
et al., 2017), but little is known about the relationship that
exists between parvalbumin-containing interneurons and the
establishment of post-traumatic depression (Earnheart et al.,
2007; Luscher et al., 2011; Fenton, 2015). Moreover, in
human depression, their action is far from being established
(Khundakar et al., 2011; Pehrson and Sanchez, 2015; Smiley et al.,
2016).
Interestingly, the NKCC1 chloride importer antagonist
bumetanide has been shown to attenuate many disorders
like ASD, Parkinson’s disease, and schizophrenia as well as
some CCI-induced consequences. This stresses the therapeutic
potential of restoring low (Cl−)i levels and an efficient
GABAergic inhibition (Lemonnier et al., 2013, 2016; Damier
et al., 2016; Xu et al., 2016; Ben-Ari, 2017). Although, it has
been previously shown that bumetanide could have various
positive effects on TBI models (Hui et al., 2016; Zhang
et al., 2017) and could also act on secondary neurogenesis
in stroke condition (Xu et al., 2016), yet nothing is known
about the early action of this compound prior to the
establishment of depressive-like behaviors (DLB). Our results
showed that brain trauma disrupts chloride homeostasis, leading
to hippocampal network disturbances and impaired neurogenesis
associated with DLB. Early restoration of chloride homeostasis,
using the NKCC1 inhibitor bumetanide rapidly after trauma,
attenuates the severity of post-traumatic alterations notably
by reducing interneuron loss. This, taken together, suggests
a therapeutic potential of this FDA-approved compound after
trauma.
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MATERIALS AND METHODS
The French ethical approved all experimental procedures
(No. APAFIS#2797-2015112016427629v8). All experiments were
performed in blind.
Controlled-Cortical Impact Model (CCI)
Ten-weeks old C57bl6-J males are housed individually in an
enriched environment, consisting in thick rolled paper (Diamon
twist, Envigo) and Dome Home (Envigo) allowing correct nesting
of the animals as requested by our French ethical committee.
They are maintained in a 12 h light/12 h dark cycle environment
with controled temperature (23 ± 2◦C), food and water are
given ad libitum. The CCI procedure is performed using aseptic
technique. Buprenorphine (0.03 mg/kg) is given intra-peritonealy
(i.p.) 30 min before surgery. Anesthesia induction is done using
4% isoflurane mixed with air and enriched with oxygen (0.3%),
for the procedure isoflurane is set to 2–2.5%, before animals
are positioned in a stereotaxic frame (David Kopf Instruments).
Body temperature is maintained at 37 ± 2◦C with a heating
pad (Harvard Apparatus). The impact is done on the right
cortex within the boundaries of the bregma and lambda after a
craniotomy is done, using a leica impactor (tip diameter 3 mm,
6 m/s speed, 1.5 mm depth and 200 ms duration). Sham animals
receive complete surgery without the impact. Before experiment,
animals were randomly assigned to each group, e.g., sham-
vehicle, sham-bumetanide (as there were no differences in all
considered tests in between sham-vehicle and sham-bumetanide,
and to clarify the message of the manuscript, this group will not
be presented in the figures), CCI-vehicle and CCI-bumetanide.
Drug Delivery
Bumetanide stock solution 20 mM (Sigma-aldrich, B3023) is
prepared by dissolving 36.4 mg of powder in 1 ml absolute
ethanol. The injected solution consists of 40 µl of stock solution
diluted in 4 ml PBS 1X. A volume of 26.7 µl par gram of
Bumetanide is injected intra-peritonealy, twice daily (9 am and
5 pm), thus corresponding to 2 mg/kg. The vehicle solution
consists in the same preparation but lacks the bumetanide
powder to respect volume and diluent. Imipramine (30 mg/kg)
is i.p injected 30 min before testing the animals for depression.
Western Blot Analysis
Animals were killed by decapitation after deep isoflurane
anesthesia. Hippocampi are quickly dissected out, flash-frozen
in liquid nitrogen and stored at −80◦C until processed. Brain
tissue are homogenized in RIPA buffer (50 mM Tris-HCl
pH 8; 150 mM NaCl; SDS 0.1%; Deoxycholic Acid 0.5%;
1% Triton X-100), containing complete Protease/Phosphatase
Inhibitor Tablet (Thermo Fisher) and loaded with Laemmli
3X loading buffer. The samples are separated in 4–15%
SDS-PAGE gel (Criterion gel, Bio-Rad) and transferred to
a nitrocellulose membrane (Whatman). After blocking in
Tris-buffered saline/0.1% tween/5% bovine serum albumin
(BSA), membranes are exposed overnight at 4◦C to primary
antibody diluted in blocking solution (Tris-buffered saline/0.1%
tween/2.5% BSA), anti-NKCC1 (DHSB, 1:2000), KCC2 [non-
commercial (Ludwig et al., 2003); 1:5000] and Phospho-Serine
940 (Rockland, 612-415-E15, 1:1000). Secondary antibodies
(anti-mouse HRP, #31430, and anti-rabbit HRP, #31460, Thermo
Fisher Scientific) are applied for 2 h at room temperature,
before a chemiluminescence assay is performed using horseradish
peroxidase-conjugated detection. Signals are revealed using ECL-
plus Western blotting reagents (ECL-plus kit, Pierce Biotech)
on the image analysis software G box (Syngene). Membranes
are then stripped using 50 mM DTT/2% SDS in 50 mM Tris-
HCl, pH 7.0 for 30 min at 65◦C, and blocked again in Tris-
buffered saline/0.1% tween/5% BSA and finally probed with
anti-α-tubulin (#62204, Life Technologies) or anti-β-tubulin
(TUBB3 18020, Biolegend) for normalization. Signal detection
and revelation are done following the same procedure as the one
for primary antibodies. Quantifications are performed using Gel
Plot Analyzer plugin (ImageJ).
Immunohistochemistry
Mice are transcardially perfused with 4% paraformaldehyde then
60 µm coronal sections are made and stained overnight at
4◦C using KCC2 (1:3000; Ludwig et al., 2003), Bromo-deoxy-
Uridin (BrdU) (Dako M0744, 1:100), DCX (Abcam, AB18723,
1:1000) and parvalbumin (Sigma P3088, 1:500), The Alexa Fluor-
conjugated secondary antibodies (1/500, Invitrogen) used 2 h
at room temperature and slices are finally counterstained with
Hoechst 33258 (10 µg/mL, Sigma-Aldrich 861405). Images are
acquired using a confocal microscope with 10, 20, 40, or 63X
objectives. The KCC2 antibody used in this study is a custom-
made antibody recognizing both a and b isoforms of KCC2
(Uvarov et al., 2007), the epitope is localized on the N-terminus
part of the protein.
KCC2 Subcellular Localization Analysis
The measure of the distribution of KCC2 fluorescence associated
with cytosolic regions, in sham and CCI condition, is performed
at high magnification (x63 objective) using the Image J software.
Plot Profiles are done using a line scan analysis through ImageJ
software. Briefly, the same straight-line is applied from the
extracellular compartment to the nucleus. The intensity profile
of each point of the line, separated by 0.1 µm, is analyzed and
compared between sham and CCI groups using t-test.
BrdU Injections and Neurogenesis
Staining
Intra-peritoneal injections of a 1 mg Bromodeoxyuridine
solution (BrdU, Sigma, 10 mg/ml) are performed at 6 days
and 1-month post brain trauma to label dividing cells in the
S-phase. BrdU is dissolved in PBS 1X. Mice received two BrdU
injections (9 am and 5 pm), the day before brain collection.
Immunohistochemistry is done using a mouse-BrdU antibody
(M0744, 1:100, Dako) to monitor dividing cells and using double
cortin (DCX) antibody to label immature newly born granular
cells. The total number of either BrdU- or DCX-immunopositive
cells are assessed within the granular layer of the dentate gyrus
(DG) after images acquisition using an apotome module at 20X
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objective (BX 40 Olympus). Pictures consist in 1 µm stack
images, the total number of stacks gives the total volume of the
DG. The total number of positive cells are expressed within the
reconstructed volume and reported to the volume, in order to
avoid any biases due to thickness differences.
Behavioral Studies
Animals are habituated to the testing room 1 h before testing.
For the open field test (OFT), mice are allowed to freely explore
the arena for 10 min (Noldus apparatus, 38.5 cm × 38.5 cm).
Parameters are detected and analyzed using the Ethovision
software (Noldus).
The forced swim test (FST) paradigm is performed in a
25◦C water with first a 2-min habituation period followed
by a 4 min recording. The time of immobility is quantified
to discriminate between swimming and non-swimming
movements. Stabilization movements are not counted as
swimming movements.
The tail suspension test (TST) is performed on a 6-min trial
and the time of immobility is again measured by the experimenter
to discriminate between movements and swinging movements.
The splash test consists of spraying a 10%-sucrose solution to the
fur of the animal, and then animals are video-monitored for a 5-
min period, during which latency to first complete sequence of
grooming and total grooming time is measured.
For the novel object recognition test, animals are exposed to
an empty open field arena (38.5 cm × 38.5 cm × 38.5 cm) for a
3-min habituation time. In a second time, animals are exposed,
in the same arena, to two identical objects for a 3-min period.
Finally, after a 1-h delay, animals return to the arena, for a third
3-min period, where one of the objects has been replaced by a new
one. The time spent close to the objects is measured and plotted
as a new versus familiar object ratio.
Acute Slices Preparation
Animals are collected on the first post-traumatic week. After
cervical dislocation, brains are rapidly removed, the hippocampi
dissected, and transverse 350 to 450 µm thickness slices are
produced using a Leica VT1000S tissue slicer (Leica VTS1200S,
Germany) in oxygenated (95% O2 and 5% CO2) modified
artificial cerebrospinal fluid (mACSF) containing, in mM: 132
choline, 2.5 KCl, 1.25 NaH2PO4, 25 NaHCO3, 7 MgCl2, 0.5
CaCl2, and 8 D-glucose. Slices are then transferred at room
temperature for 1–2 h before chloride and electrophysiological
recordings in oxygenated (95% O2 and 5% CO2) normal artificial
CSF (ACSF) containing, in mM: 126 NaCl, 3.5 KCl, 1.2 NaH2PO4,
26 NaHCO3, 1.3 MgCl2, 2.0 CaCl2, and 10 D-glucose, pH 7.4.
In vitro Electrophysiological Recordings
Hippocampal slices are individually transferred to a recording
chamber maintained at 30–32◦C and continuously perfused
(2 mL/min) with oxygenated normal or adapted ACSF.
Extracellular field recordings are made using tungsten wire
electrodes (diameter: 50 µm, California Fine Wire, Grover Beach,
CA, United States). Recording electrodes are positioned in a
pyramidal cell layer of CA3 subfield, and signals are amplified
using custom- DAM-8A amplifiers (WPI, GB; low-pass filter:
0.1 Hz; high-pass filter: 3 kHz; gain: x1000) and then acquired
using an A/D converter (Digidata 1440A, Axon Instruments).
Clampfit 10.1 (Axon Instruments) software is used for the
acquisition and analysis of the network activity. Isoguvacine and
bumetanide are purchased from Sigma.
Volumetry Analysis
Coronal 10 µm thick cryostat sections were stained by
cresyl violet, digitized and analyzed using an 1.25X objective
and computer image analysis system (Optimas 6.51, Optimas
Corporation, Bothell, WA, United States). Lesion volume
measurement was performed essentially as previously described
(Schaible et al., 2014).
Parvalbumin-Containing Interneurons
Quantification
Forty µm sections were stained using a mouse-Parvalbumin
antibody (Sigma-Aldrich, 1:500) and counterstained with
Hoechst 33258 (Sigma-Aldrich, 10 µg/mL in PBS). The
quantification was done in granular layer of the DG at 40X
objective. All experiments were manually performed in blind.
As done with the BrdU images, pictures consist of 1 µm stack
images, the total number of stacks gives the total volume of the
DG. The number of positive cells is expressed in percentage
within the reconstructed volume to avoid any biases.
Statistical Analysis
All mean values are given with the standard error mean (SEM).
Normality was tested for each distribution and was set to 5%.
Two-tailed Student’s, Mann–Whitney test or one-way ANOVA
were used accordingly using Prism software (GraphPad Software,
Inc., La Jolla, CA, United States). Box plot report the median,
the interquartile range and the total range data and represent as
following: ∗p< 0.05; ∗∗p< 0.01; ∗∗∗p< 0.001.
RESULTS
Behavioral Analysis of Depressive-Like
Behavior
The CCI protocol triggers the appearance of comorbidity factors
at later stages, e.g., depression-like behavior. We first performed
behavioral tests to ensure that the mice model of brain trauma
used in this study exhibited DLB. We performed a FST (Poleszak
et al., 2006; Tao et al., 2016), TST (Castagné et al., 2011; Fan et al.,
2016), OFT (Tao et al., 2016), splash test (Marrocco et al., 2014;
Petit et al., 2014) and finally novel object recognition (García-
Pardo et al., 2016; Egeland et al., 2017). All those experiments
were carried out 1 month after the CCI (1mpCCI). In the OFT,
we observed significant changes in the time spent by the animal
in the center of the arena (sham 50.83± 13 vs. CCI 60.86± 22 s,
sham n = 30, CCI n = 20, p = 0.04, Figure 1A) whereas there was
no significant difference in the total distance (sham 3308 ± 160
vs. CCI 3571 ± 155 cm, p = 0.2, Figure 1A), nor in the average
speed of the animals (sham 5.8 ± 0.2 vs. CCI 6.2 ± 0.3 m/s,
p = 0.3, Figure 1A). Then, we moved to more specific tests
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FIGURE 1 | Continued
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FIGURE 1 | Bumetanide ameliorates CCI induced behavioral changes. (A) Open field test (OFT): plots represent both the time spent by the animal in the arena
center, the total distance traveled and the average speed of the animal during the 10 min test, sham n = 30 and CCI n = 20, we used unpaired t-test for the
comparison on the two population. (B) Forced swim test (FST): immobility time in a 25◦C water for 4 min, sham n = 15, CCI n = 12, CCI + bum = 6, CCI +
imipramine = 6 and CCI + bum + imipramine = 6. (C) Tail suspension test (TST): immobility time for 6 min (sham n = 10 and CCI n = 10. (D) The Novel Objet
Recognition shows changes in the exploration time, the results are presented on a ratio of time of new versus familiar, n = 16, 15, and 17, respectively. (E) Splash
test analyzes the total grooming time and the latency to the first complete sequence, n = 26, 27, 28, respectively. (F) After 1 week of i.p. bumetanide twice daily
injection (20 µM). Treated animals showed improvement in the OFT compared to non-treated animals, n = 20. Statistic analysis is done using one-way ANOVA test
with either Kruskal–Wallis, for non-parametric data or Tukey’s comparison of multiple test for parametric data as post hoc treatment to compare between conditions.
(G) Volumetry analysis: volume are calculated by summation of areas multiplied by distance between sections (500 µm) n = 10 brains per condition. The graph
shows the ipsi over contralateral volume ratio, 7 days post cci from bumetanide- and vehicle-treated mice. Statistical significance is tested using Mann–Whitney test,
p = 0.21. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001.
for depression using the FST and TST paradigm. We found
a significant increase in the immobility time of CCI animals
versus sham (sham FST 88.8 ± 6 vs. CCI FST 152.8 ± 12 s,
p< 0.0001, n = 12 and 15 animals respectively; Figure 1B) (sham
TST 165 ± 54 vs. CCI TST 246.7 ± 18 s, p = 0.007; Figure 1C).
To confirm this was indeed a DLB, we injected imipramine
(30 mg/kg, n = 20 animals), a classical anti-depressant compound
given before the test. Interestingly, this compound could be used
during behavioral tests, both in an acute and chronic manner.
In the acute way, as we used in the study, it is given 30 min
before testing animals (Cryan et al., 2005; Castagné et al., 2011;
Zhao et al., 2015). In agreement with the literature, we observed
a strong effect on the phenotype (CCI FST 152.8 ± 12 vs. CCI
imipramine 89.6 ± 30 s for imipramine treated animals, six
animals). The same effect on immobility time was observed on
the TST (CCI 246.7 ± 18 versus CCI imipramine 168.6 ± 31 s,
n = 10 per condition) (Figure 1C). Performing a novel object
recognition test, a well-known test for MDD (Egeland et al.,
2017), we observed a significant change in the time spent by the
animal around the new object after CCI, as shown in the new
versus familiar time ratio depicted in Figure 1D (sham 2.15± 0.2
vs. CCI 1.18 ± 0.15). Finally, after a 10%-sucrose solution was
sprayed to the fur, the grooming behavior was assessed (Amini-
Khoei et al., 2017). We observed an increase in the time to
perform the first entire grooming sequence (sham 93.5 ± 5 vs.
CCI 129.9 ± 12 s, n = 23 and 24 per condition) without any
significant change in the total grooming time (sham 168 ± 7 vs.
CCI 142± 9 s) (Figure 1E).
Early Application of Bumetanide
Rescues CCI-Induced Depressive-Like
Behavior
We then subjected CCI mice to twice-daily i.p. injections of
bumetanide (2 mg/kg) during the first week after CCI. The sham
and the CCI-vehicle animals received the same procedure with
the vehicle solution as described in “Materials and Methods.”
This time window was chosen as the blood–brain barrier (BBB)
is considered to remain open (Dachir et al., 2014). Behavioral
analyses of the cohorts were performed again after 1 month.
Analysis of these results revealed a potent action of bumetanide
on all the behavioral tests. This indicates a major role of CCI-
induced changes in chloride homeostasis in the induction of
DLB. The effect of bumetanide was significant in both on the
immobility time using FST (p = 0.0002, Figure 1B) and the TST
(p = 0.03, Figure 1C), but also on the exploratory paradigm of
the OFT (p = 0.04, Figure 1F). The other sets of experiments also
showed a beneficial role of bumetanide on the grooming behavior
when using the splash test (p = 0.0005, Figure 1E) and finally
we observed a very potent effect on the novel object recognition
paradigm (p = 0.0005, Figure 1D). Interestingly, we did not
observe any significant difference in the FST paradigm between
imipramine-treated animals and bumetanide-imipramine double
treated animals (Figure 1B), indicating no additional effect of
bumetanide over imipramine.
The accumulation of intracranial pressure is a comorbidity
of closed-head TBI and this is produced by the formation
of edema. Previous work suggested that changes in chloride
homeostasis can have an ameliorating effect on trauma-induced
edema (Lu et al., 2007) that could mediate the positive effects of
inhibiting changes in chloride transport. Significant formation of
intracranial pressure is not expected in this study, as it is an open-
head CCI model. To investigate the effect of bumetanide on lesion
size, we performed volumetric analysis on both bumetanide- and
vehicle-treated CCI brains. By performing cresyl-violet staining,
we defined the brain lesion size (Figure 1G). The volume ratio
between contralateral and ipsilateral hemispheres showed that,
at 7 dpCCI, there was no significant modification in the lesion
size after bumetanide application (CCI 0.88 ± 0.01 vs. CCI
bumetanide 0.89± 0.01, n = 10) (Figure 1G).
CCI-Induced Changes in Hippocampal
Network Activity and Inhibitory Strength
of GABAergic Signaling
Studying changes in neuronal activity is important to understand
the appearance of MDD. As the hippocampus is one of the main
regions known to be involved in the occurrence of DLB, the
behavioral tests led us to focus on the hippocampal network
activity. The action of bumetanide on the prevention of post-
traumatic DLB suggests that changes in chloride homeostasis
and in GABAergic neurotransmission in the hippocampus
may be involved in the process. Indeed, impairment in
chloride homeostasis after TBI has already been shown in
the hippocampus in ex vivo paradigm (Rivera et al., 2004;
Shulga et al., 2012). In order to assess whether GABA(A)
transmission was affected in our model, we monitored the
effect of GABA(A) receptor activation on extracellular field
potentials in the hippocampus. As spontaneous activity of
the DG is known to be quite low (Spruston and Johnston,
Frontiers in Molecular Neuroscience | www.frontiersin.org 6 February 2019 | Volume 12 | Article 12
fnmol-12-00012 February 2, 2019 Time: 18:17 # 7
Goubert et al. Bumetanide a New Preventive Anti-depressant
1992; Kvajo et al., 2011) (Supplementary Figure 1), we
decided to record multi-unit activity (MUA) from the CA3
hippocampal region. Acute hippocampal slices, both from ipsi-
and contra-lesional hemispheres at 3 days after CCI were
recorded in the presence of 10 µM isoguvacine, a potent
and selective GABA(A) agonist. Such treatment exerts an
excitatory action on the action potential spiking frequency
on ipsi- but not on the contralateral hippocampus at 3
dpCCI (Figure 2B), as compared to the sham condition
(Figure 2A). This set of results suggests that GABAergic
transmission is modified, rendering the network more excitable.
The strong block of the depolarizing effect of isoguvacine by
bath application of 10 µM bumetanide (n = 2 animals, 4 to
5 slices per animal) (Figure 2C) indicates the involvement of
chloride imbalance in the CCI-induced changes in GABA(A)
responses.
Changes in Chloride Regulatory Proteins
After CCI
We then investigated whether changes in network excitability
could be explained by changes in dynamics of chloride
extrusion efficacy. To estimate to what extent chloride-regulatory
proteins are affected during the early post-traumatic time
window, CCI, NKCC1, and KCC2 protein expression levels
were followed during the first post-traumatic week in the
hippocampus.
We observed a significant decrease in KCC2 protein
expression rapidly after the trauma with a recovery on the 7th day
at the ipsi and contralateral hippocampus (Figures 3A,B). For
NKCC1 analysis, we did not observe any significant changes in
protein levels in the hippocampi (Figures 3A,B). Similar results
were obtained for KCC2 and conversely for NKCC1 at mRNA
levels in the injured hemisphere (Supplementary Figure 3).
CCI-Induced Internalization of KCC2
Plasma Membrane
To study a possible link between protein expression and network
activity changes, we then investigated whether KCC2 expression
and more specifically its subcellular distribution were affected.
We used a specific KCC2 antibody to examine the cellular
distribution of KCC2. We decided to focus on DG, a hippocampal
region where changes in network activity is already reported after
TBI (Bonislawski et al., 2007) and as the DG region is involved
in depression. In sham granular cells, KCC2 was mainly located
near the membrane of cell bodies (Figure 3C). In contrast, the
labeling of KCC2 in granular cells was largely cytoplasmic 3
dpCCI (Figure 3D). The cellular distribution of KCC2 in sham
and 3 dpCCI was significantly different with a peak around the
membrane for sham granular cells (sham 64.09 ± 4.550 N = 2
n = 60 vs. 3 dpCCI 44.34 ± 1.83 N = 3 n = 88), together
with staining dispersion over the cytoplasmic compartment in
granular cells at 3 dpCCI (sham 13.56 ± 1.011 N = 2 n = 60 vs. 3
dpCCI 31.92 ± 1.54 N = 3 n = 88) (Figure 3E). This suggests an
internalization of KCC2 after TBI and is in agreement with robust
changes in chloride homeostasis and GABAergic transmission in
the DG.
To examine if GABAergic transmission is altered all over
the hippocampus, we decided to also study the functionality
of chloride transport using Clomeleon mice in the CA1 region
(Berglund et al., 2006) (Supplementary Figure 2). We found
that chloride extrusion was significantly reduced at 3 and 5 but
not at 7 dpCCI compared to sham condition, thus confirming
the phenotype observed using the MUA approach and the
biochemical techniques. Our results suggest a general effect
of CCI on chloride transport into the hippocampal formation
through the reduction of KCC2 expression and function.
Taken together, these results show an imbalance in the
NKCC1/KCC2 ratio in favor of NKCC1 and a loss of function
of KCC2.
Bumetanide Rescues Post-traumatic
Impairment in Secondary Neurogenesis
Previous results suggested that the effect of antidepressants on
proliferation of adult born neurons of the DG might be involved
in the mechanism of action of these compounds. Considering
the prophylactic anti-depressant effect of bumetanide found in
this study, it is plausible that part of the antidepressive effect is
mediated by changes in proliferation. Thus, we monitored both
the proliferative cells and newly born neurons at the end of the
first post-traumatic week. Neurons were labeled with double-
cortin (DCX), a marker of immature neurons (Ren et al., 2015),
and proliferative cells were stained with bromo-deoxy-Uridin
(BrdU) to assess the relative number of dividing cells within the
granular layer of the DG (Samuels et al., 2015). The number of
positive cells was calculated on a defined slice volume (see section
“Materials and Methods”) and expressed as the total number of
positive cells per volume. We observed a significant CCI-induced
reduction in the number of the DCX positive neurons within
the DG both in the ipsi- and contra-lesional hippocampi at 7
dpCCI (sham ipsi 168.3 ± 26.8 vs. CCI ipsi 45.9 ± 11.09 and
sham contra 158.8 ± 15.3 vs. CCI contra 89 ± 21.8; respectively
6 and 4 animals, 4 slices per animal) (Figures 4A,C), together
with an increase in the number of BrdU positive cells within the
DG (sham ipsi 45 ± 5.8 vs. CCI ipsi 53.5 ± 4.3 and sham contra
43.5 ± 4.2 vs. CCI contra 81.3 ± 6.7, n = 4 and 6 animals, 6
slices per animal) (Figures 4A,C). Bumetanide treatment reduced
first the number of BrdU positive cells (CCI bumetanide ipsi
27.9 ± 3.8 and contra 54 ± 3, n = 4 animals, 6 slices per animal)
(Figures 4A–C) and triggered an increase in the number of newly
generated neurons (CCI bumetanide ipsi 69.2 ± 11 and contra
138.4± 11, n = 4 animals, 4 slices per animal) (Figures 4A–C).
Interestingly, 1 month after trauma, it was not possible to
find any significant differences in the number of BrdU+ (sham
contra 29 ± 1.3 vs. CCI contra 26 ± 1.6) and in the number
of DCX+ neurons (sham contra 124 ± 6.1 vs. CCI contra
91.3± 8.5) within the contralateral hippocampus of CCI animals
compared to sham animals (Figures 4B–D). On the contrary, a
significant and persistent loss of newly generated neurons (sham
ipsi 145.3 ± 7.3 vs. CCI ipsi 85.3 ± 11.3) with no significant
change in BrdU positive cells (sham ipsi 28.3 ± 1.9 vs. CCI ipsi
34.9± 3.9) (Figures 4B,D) was still present at the ipsilateral side,
indicating a permanent change at the DCX level compared to
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FIGURE 2 | Network activity recording and chloride extrusion efficacy. (A) Effect of isoguvacine (10 µM) on hippocampal networks from ipsi and contralateral
hippocampus from sham animals. (B) Effect of isoguvacine (10 µM) on hippocampal networks at 3 days post-CCI, Top left: example trace of spontaneous
extracellular field potentials recorded in ipsilateral hippocampus. Middle: corresponding time course of spike frequency changes. Top right: graph of non-normalized
spike frequencies. Middle left: example trace of spontaneous extracellular field potentials recorded in contralateral hippocampus. Middle: corresponding time course
of spike frequency changes. Middle right: graph of non-normalized spike frequencies. Bottom: average histograms of normalized spike frequencies. (C) The same as
in (B) with acute pre-treatment of bumetanide (10 µM). 3 days post-CCI (n = 2 animals, 4–5 slices per animal). ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001.
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FIGURE 3 | CCI-induced changes in chloride co-transporters expression. (A) The left panel represents the KCC2 protein expression normalized to the neuronal
marker β3-tubulin on the ipsilateral hippocampus. Protein expression over the time is expressed in comparison to the sham conditions. On the right panel, NKCC1
protein expression is shown normalized to the ubiquitous marker α-tubulin. Protein expression over the time is expressed in comparison to sham conditions, n = 8
per condition. One-way ANOVA test is performed and expressed as following ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001 together with Kruskal–Wallis post hoc test.
(B) Same as (A) but in the contralateral hippocampus. (C–E) KCC2 staining in granule cells. (C) Sham at 3 dpCCI. The labeling is at the cellular membrane
(arrowhead) and the cytoplasm is almost devoid of KCC2 labeling. (D) 3 dpCCI. KCC2 is found in the cytoplasmic cell compartments (arrowheads). (E) Histograms
representing the distribution and quantification of the intensity of fluorescence in 3 dpCCI cells (red curve) in sham (black curve). Statistical analysis represents the
difference in each sub region of the cell, namely membrane, cytoplasm, and nuclear staining. Scale bars: 50 and 10 µm.
the transient one observed in the contralateral side. This suggests
that both hemispheres are involved in the early settling up of
post-traumatic depression.
Ambient GABA, that is provided by the activity of DG
interneurons, may play a role in the proliferation and migration
of granular cell progenitors (Duan et al., 2008). We then wonder
if GABAergic signaling known as a neurogenesis modulator
(Moss and Toni, 2013; Samuels et al., 2015; Alvarez et al., 2016)
could contribute to the etiology of post-traumatic depression
(Cryan et al., 2005). Therefore, it appeared interesting to
quantify parvalbumin interneurons, which are known to play a
critical role in post-traumatic consequences (Drexel et al., 2014;
Hsieh et al., 2014; Khodaie et al., 2014). We quantified the
parvalbumin-containing interneurons survival in the granular
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FIGURE 4 | Effect of bumetanide on CCI-induced changes in secondary neurogenesis. Secondary neurogenesis in the dentate gyrus. (A) Double-cortin (DCX) and
BrdU labeling at 7 days post-CCI in the ipsilateral (left) and contralateral (right) dentate gyrus of sham, CCI vehicle and bumetanide-treated animals. Dotted lines
delimit granular layer of dentate gyrus (scale bar = 100 µm). (B) Same as in (A) at 1 month post-CCI. (C) Quantification of BrdU and DCX positive cells 7 dpCCI in
the ipsilateral (left) and contralateral (right) dentate gyrus of sham, CCI vehicle and bumetanide-treated animals. (D) Same as in (C) at 1 month post-CCI. DCX 7 days
post-CCI: n = 6 animals per condition, 3 slices per animal; 1 month post-CCI; n = 4 animals per condition, 2–4 slices per animal. BrdU 7 days post-CCI: n = 5 sham
n = 6 CCI vehicle and 6 CCI bumetanide, 2–6 slices per animal, 1 month post-CCI: n = 3 sham n = 4 CCI vehicle and 4 CCI bumetanide, 3–4 slices per animal. All
sets of data were analyzed using one-way ANOVA test with Tukey’s post hoc test. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001.
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FIGURE 5 | Effect of bumetanide on CCI-induced parvalbumin positive interneuron death. (A) Ipsilateral hippocampus: left panel example of parvalbumin and
Hoechst immunostaining, from sham and CCI mice. On the right panel, quantification of parvalbumin positive interneurons in the dentate gyrus normalized to sham
values. n = 5 animals per condition. (B) Same as (A) but in contralateral hippocampus, the histogram shows reduction in the number of parvalbumin-containing cells
in the DG, n = 5 animals per condition. (C) Effect of bumetanide in parvalbumin interneuron survival in the ipsilateral hippocampus. The histogram shows a significant
reduction in the cell loss in the presence of bumetanide but this is though significantly less as compared to sham, n = 5 animals per condition. (D) Contralateral
hippocampus: bumetanide injection reduces interneurons loss, n = 5 animals per condition. All sets of data were analyzed using one-way ANOVA test with Tukey’s
post hoc test. One-way ANOVA test is expressed as following ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001.
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layer of the DG, both from ipsi and contralesional hippocampi
at 7 dpCCI. Both sides showed a significant reduction of the
number of parvalbumin-positive interneurons, compared to
sham condition (ipsi 67 ± 4.6%, ∗∗∗, n = 5 animals, 25 slices;
contra 40 ± 6%, ∗∗∗, n = 5 animals, 26 slices, Figures 5A,B).
This loss was significantly reduced by bumetanide application at
the contralateral (101 ± 5.3%, ∗∗∗, n = 5 animals, 3 to 4 slices
per animal, Figure 5D) and ipsilateral side (52 ± 3.9%, ∗∗, n = 5
animals, 3 to 4 slices per animal, Figure 5C), compared to the CCI
condition itself. Thus, the effect of bumetanide on DG secondary
neurogenesis could be partly caused by changes in ambient
GABA that is provided by the activity of DG interneurons.
DISCUSSION
Our fundamental issue was to understand the consequences of
the depolarizing GABA at both early and late stages after brain
trauma. Using our experimental model, we found that CCI-
induced DLB is strongly sensitive to trauma-induced changes
in GABA(A)-mediated responses. The depolarizing GABA(A)
responses, at very early stages after CCI, lead to DLB phenotypes
at chronic stages. The question raised by these results is how
changes in GABA(A) transmission are involved in the CCI-
induced rearrangements in the hippocampal network, leading
to abnormal behavior (Figure 6). Our analyses after CCI
highlight long-term impairment of mood-associated behavior.
CCI mice exhibited a phenotype that mimicks a decreased
defensive behavior in an unfamiliar environment, as it has been
described in other anxiety-like behavioral tests (Pandey et al.,
2009; Stemper et al., 2015). Surprisingly, blocking GABA(A)-
mediated depolarization, with the specific inhibitor bumetanide
at early stages after CCI, resulted in a significant long-term
reduction in DLB, long after the end of the treatment with
bumetanide. These results pinpoint an important role of the
qualitative changes in GABA(A) responses and suggest that
bumetanide itself could act in a prophylactic manner as an anti-
depressant compound; this was proven to be independent of its
effect on lesion volume in a model of cerebral ischemia (Xu et al.,
2016) and in our hands. Consistent changes in KCC2 and NKCC1
expression have been found in a number of trauma models,
as well as in resections form temporal lobe epilepsy (Pallud
et al., 2014). Qualitative changes in GABA(A) transmission and
levels of chloride regulatory proteins have not however been
well-characterized in CCI models (Robel et al., 2015; Hui et al.,
2016). In the present study, we show that KCC2 expression is
significantly changed in the hippocampus during the first week
following trauma. Interestingly, although these changes occur
shortly after CCI in both the ipsi and contralesional hippocampi,
they remain transient as KCC2 expression levels return to normal
values in both hippocampi. Changes in chloride extrusion efficacy
are consistent with this biochemical conclusion, thus resulting in
a switch in GABA(A)-mediated network excitability as opposed
to the control condition. As expected, the effects observed in
the contralateral hippocampus are milder but present. This put
the question to how these transient changes could have a long-
term effect on brain circuitry. Previous results showed that almost
all antidepressants have significant effects on proliferation in
the DG and production of newborn neurons. This has led to
the hypothesis that proliferation in the DG is associated with
DLB. While CCI induced a significant increase in proliferation
in the contralateral DG alone, the number of DCX positive
immature neurons was significantly diminished on both sides.
The acute effect of bumetanide that we observe, leads to increased
neuron production and reduced proliferation. The results we
show here propose that the neurogenesis itself is modified
leading to a reduction in neuron production. The remaining
question is how this transient KCCs effect could last longer.
Our results provide evidences that transition from BrdU positive
cells to double-cortin positive immature neurons after CCI is
significantly affected by blocking GABA(A)-mediated responses
at early stages. This, together with the interneurons cell death,
leads us to propose that GABAergic neurotransmission, either
qualitative and quantitative, impacts the secondary neurogenesis
(Scharfman and McCloskey, 2009; Toda and Gage, 2017). Further
studies are now needed to discriminate the exact role of chloride
transporters in both cell cycle and cell differentiation.
Other TBI features must be taken into account to explain
the action of bumetanide seen in this study. Among them,
inflammation is the most common phenomenon happening after
brain insults (Solmaz et al., 2009; Anderson, 2013; Anderson
et al., 2014). This inflammation could have several effects, among
which, cell-death is one of the most prominent effects. It has
been shown in other models that inflammation is associated
with a massive loss of hippocampal formation write in epilepsy
(Aldenkamp and Bodde, 2005; Swartz et al., 2006; Jefferys, 2010;
Peng et al., 2013) or TBI models (Swartz et al., 2006; Morrison
et al., 2011; Belousov et al., 2012; Acosta et al., 2013) and more
particularly in the DG region (Lowenstein et al., 1992; Kourdougli
et al., 2015; Sun et al., 2015). In that context, neuronal cell
death and more specifically Parvalbumin positive cell death is
one particular phenomenon both in epilepsy (Huusko et al.,
2015) and in TBI models (Santhakumar et al., 2001; Cantu
et al., 2014; Huusko and Pitkänen, 2014). In those studies, even
with a milder model, they were able to show a really strong
effect in Parvalbumin cell survival. Although it’s known that
principal cells required KCC2 for their survival (Lee et al., 2007;
Pellegrino et al., 2011), nothing is known about interneurons
survival in that particular context. One explanation could be that
interneurons are not dying but lose their biochemical identity
after trauma since this has been demonstrated in other trauma
models (Unal-Cevik et al., 2004; Todkar et al., 2012; Kelley
et al., 2016). In our model, interneurons also lose their GAD67
immunoreactivity but this loss is not transient as shown in
other models (Kelley et al., 2016) since it persists after 1 month,
thus, confirming a significant and permanent reduction in the
number of parvalbumin-positive interneurons. Disruption of
the BBB is also an important in leading to cell death and
brain invasion. In our model the bbb remains open during
the first post-traumatic week, thus the crossing of the BBB is
possible during that specific time period (Dachir et al., 2014).
In other studies, its disruption was observed (Cernak, 2005;
Davidsson and Risling, 2011; Zhu et al., 2018) and proposed to
be linked to glial and microglial invasion. Again, further studies
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FIGURE 6 | Schematic scheme of TBI time course events. Please note that series of events taking place right and shortly after trauma are sequentially arranged
leading to both short and long term consequences leading to decreased cognitive performance.
are necessary to determine the exact contribution of chloride
homeostasis in inflammation. One other brain trauma feature we
need to add to this discussion is the cell volume regulation and
more particularly, the neuronal volume regulation. It has been
proposed that, after brain insults, neurons could have volume
variation in an aquaporin-independent process (Hoffmann et al.,
2009; Zeuthen, 2010; Ullah et al., 2015). This aspect needs to
be linked with the structural plasticity observed in the principal
cells after trauma in which both the dendritic tree (Winston
et al., 2013; Wang et al., 2016) and dendritic spines are affected
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(Swann et al., 2000). One possibility could be that bumetanide,
through its action on hyperexcitability, could prevent protein
remodeling observed after TBI, thus preventing volume changes.
One of the questions of interest in our case regards bumetanide
action and the so-called therapeutic window we used. We decided
to work on the first post-traumatic week due to the poor BBB
permeability for bumetanide (Töllner et al., 2014), and as BBB is
known to be opened at that stage (Dachir et al., 2014). Even if the
peripheral action of bumetanide could have effect in the CNS, we
consider our main effect to be central as shown by the effect on
parvalbumin survival and on neurogenesis.
Although the CCI-induced changes in chloride regulatory
proteins and GABA(A) transmission are consistent with short-
term effects on excitability, it is less obvious how this is involved
in a long-term effect after trauma. A possible contributing
explanation could be related to cell death of interneurons. We
have previously shown that the qualitative changes in GABA(A)
responses is tightly linked with the survival mechanism of injured
neurons (Pellegrino et al., 2011; Shulga et al., 2012). Changes in
the interneuron population leading to changes in GABA release
could significantly change the excitability of the network (Hsieh
et al., 2014; Shiri et al., 2014). In some pathological contexts,
such as temporal lobe epilepsy and TBI as well as in another
different model of acquired epilepsy, parvalbumin interneurons
are known to be very sensitive to death (Drexel et al., 2011;
Hsieh et al., 2014) and their loss is involved in the dentate
gyrus hyperexcitability triggered by aberrant sprouting (Zhang
and Buckmaster, 2009). Altogether this highlights that both can
lead to changes GABA polarity at early stages and impaired
GABAergic signaling. We have proposed that bumetanide could
prevent trauma induced cell death (Shulga and Rivera, 2013;
Hui et al., 2016). This mechanism involved the block of the
post-traumatic depolarizing effect of GABA(A) receptor that is
produced by KCC2 functional downregulation (Lee et al., 2011;
Pellegrino et al., 2011; Winkelmann et al., 2015; Hui et al.,
2016). The results presented here clearly show that bumetanide
prevents CCI-induced interneuron death at least in the DG. Thus,
the previously shown mechanism for trauma-triggered apoptosis
of principal cells could also be relevant for interneurons. The
activity of parvalbumin interneurons has been linked to changes
in secondary neurogenesis in the DG. Released ambient GABA
from hilar interneurons, and this is of primary importance for
regulating the proliferation state of cells within the DG (Boldrini
et al., 2013; Moss and Toni, 2013; Samuels et al., 2015; Alvarez
et al., 2016). Thus, the effect of bumetanide on interneuron
survival could contribute to the short and long-term effects on
DG proliferation (Sun et al., 2012).
In the present study we have mainly focused on DLB but
bumetanide amelioration of other pathological behaviors may be
also present. It will be highly interesting to supplement these
studies with other cognitive tests for, e.g., learning and memory
together with social interaction paradigms. We show that each
hemisphere reacts to the brain trauma to different extents and
with different kinetics. This highlights that the consequences in
the contralateral hemisphere are as important as in the ipsilateral
side (Khalilov et al., 2003), and thus cannot be considered as an
independent structure in the etiology of DLB. This result also
prompts testing of the specific compound to block NKCC1 able
to penetrate the BBB or promote KCC2 function after CCI to
restore GABAergic activity (Gagnon et al., 2013; Medina et al.,
2014; Puskarjov et al., 2014).
CONCLUSION
Our study pinpoints the contribution of the depolarizing GABA
in the establishment of the TBI-induced DLB. This work opens
new perspectives to treat TBI-associated psychiatric disorders
and suggests the use of bumetanide as a potential prophylactic
agent.
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